Market overview

CTF is a trifluoromethylpyridine made from 3-picoline by chlorination and fluorination. It is the building block for aryloxyphenoxypropionate herbicides such as fluazifop-P-butyl, for pyridyloxy insecticides and for some pharmaceuticals, and it is the direct precursor to DCTF. Supply depends on Chinese vapour-phase chlorofluorination capacity.

The question this report answers
How large is the CTF market, who produces it, and how does its split between merchant sales and conversion to DCTF shape supply to 2035?

1. Demand: who uses CTF and where it is growing

Herbicides are the largest use, led by fluazifop-P-butyl, with China and India as the main consuming regions.

Demand by application (share of 2025 consumption, Market Krystal analysis)
– Herbicides (fluazifop-P-butyl, haloxyfop): 55%
– Insecticides (chlorfluazuron, pyridalyl): 20%
– Pharmaceutical intermediates: 15%
– Liquid-crystal, specialty and R&D: 10%
Publishers name agrochemicals, pharmaceuticals and specialty uses without volume shares; Verified Market Research gives North America about 35% of value, which Market Krystal treats as a value view and replaces with a volume-based split from active-ingredient synthesis locations.

Demand by region (share of 2025 consumption, Market Krystal analysis)
– China: 50%
– India: 15%
– North America: 12%
– Europe: 12%
– Japan and rest of world: 11%

Where demand grows fastest to 2035
– Agrochemicals: The market grows 6.3% a year to 2033, with agrochemicals the core application (Verified Market Research)
– Pharmaceutical intermediates: CTF is used in the HIV drug tipranavir, and TFMP pharma demand has risen steadily for 30 years (Ishihara Sangyo Kaisha)

2. Supply: who makes CTF and how much

Chinese producers dominate, including Shandong Huimeng, Join Dream Fine Chemical, Hangzhou Verychem and Sinochem Lantian, with Ishihara Sangyo Kaisha as the technology originator. Merchant capacity is indicative at 10-15 kt a year, with Shandong Huimeng stating 2,000 t/yr; more CTF is made captively as the feed for DCTF (Shandong Huimeng Bio-tech, Sinochem Lantian).

Main producers and capacity
– Shandong Huimeng Bio-tech (China): 2,000 t/yr
– Sinochem Lantian (China): Two-stage 3-picoline chlorofluorination to CTF as DCTF feed (Sinochem Lantian / USPTO)
– Ishihara Sangyo Kaisha (Japan): TFMP process originator; CTF for fluazifop
– Join Dream Fine Chemical (China): Named leading CTF producer (Verified Market Research)
– Thermo Fisher Scientific (USA): Catalogue supply only (100 g, 97-98%)

Production by region (share of 2025 output, Market Krystal analysis)
– China: 85%
– Japan: 8%
– India and other: 7%

Trade and supply-demand balance
China is the main exporter to India, Europe and the Americas; most other regions import CTF or its downstream actives (Market Krystal estimate).

3. Value chain: from feedstock to end market

3-Picoline + Chlorine + Anhydrous hydrogen fluoride → CTF → Herbicides (fluazifop-P-butyl, haloxyfop), Insecticides (chlorfluazuron, pyridalyl), Pharmaceutical intermediates

Raw materials
– 3-Picoline: Pyridine backbone; links CTF to pyridine-base producers (Ishihara Sangyo Kaisha)
– Chlorine: Side-chain and ring chlorination (Sinochem Lantian / USPTO)
– Anhydrous hydrogen fluoride: Converts CCl3 to CF3; main fluorine cost (Ishihara Sangyo Kaisha)

Production route
3-Picoline undergoes simultaneous vapour-phase chlorination and fluorination over a fluidised-bed catalyst to give CTF, or 2-chloro-5-trichloromethylpyridine is exchanged with HF (Ishihara Sangyo Kaisha, Sinochem Lantian).

Downstream
CTF is etherified with hydroquinone derivatives to fluazifop-P-butyl and haloxyfop precursors, used in pyridalyl and chlorfluazuron chains, and chlorinated further to DCTF.

Price, cost and margin
Cost follows 3-picoline, chlorine and HF; producers balance CTF sales against conversion to higher-value DCTF. CTF trades at an indicative USD 13-16/kg. Producers earn more by converting CTF to DCTF or actives than by selling it.

Where the chain is tightest
Selectivity of vapour-phase chlorofluorination sets yield and by-product load across both CTF and DCTF.

Who sits where in the chain
– Ctf production: Shandong Huimeng Bio-tech, Join Dream Fine Chemical
– Ctf and dctf: Sinochem Lantian
– Technology and actives: Ishihara Sangyo Kaisha
– Intermediates and actives: Inner Mongolia Yuanzheng Fine Chemicals
– Distribution: Thermo Fisher Scientific

4. Market size: what demand, supply and price add up to

Market Krystal preliminary estimate (2025)
Verified Market Research puts CTF at USD 105.05 mn in 2025, reaching USD 171.26 mn by 2033 at 6.3% a year. LP Information and Bosson Research sell CTF reports without public figures. Market Krystal sizes merchant CTF at roughly 5-8 kt a year from fluazifop-P-butyl, haloxyfop, chlorfluazuron and pharma uses, excluding volume converted captively to DCTF, valued at an indicative USD 13-16/kg. The published figure falls inside this range. On this basis we use USD 70-120 mn. Confidence grade B: published estimates exist; the volume or price cross-check is partial.

How published estimates compare
Verified Market Research is the only publisher with a public figure, and its USD 105.05 mn falls inside Market Krystal's range. Market Krystal counts merchant volume only and treats CTF converted to DCTF as captive.

Key figures at a glance (third-party, cited)
– CTF market USD 105.05 mn in 2025, forecast USD 171.26 mn by 2033 at 6.3% CAGR (Verified Market Research)
– North America holds about 35% of market value (Verified Market Research)
– Shandong Huimeng states 2,000 t/yr CTF capacity (Shandong Huimeng Bio-tech)
– CTF is used in fluazifop-butyl and the HIV drug tipranavir (Ishihara Sangyo Kaisha)
– Inner Mongolia Yuanzheng built 10,000 t/yr of 2-chloro-5-chloromethylpyridine plus haloxyfop-R-methyl and fluazifop-P-butyl units (AgroPages)

5. Outlook to 2035 and scenarios to 2047

Regulation and substitution
Classed toxic if inhaled and suspected mutagen (H331, H341), which raises handling cost; demand follows fluazifop and haloxyfop registrations.

Recent developments among key stakeholders
– May 2026: Verified Market Research updated its CTF report, sizing 2025 at USD 105.05 mn (Verified Market Research)
– Feb 2025: Sinochem Lantian was granted a US patent for DCTF from CTF made by two-stage 3-picoline chlorofluorination (USPTO)
– Aug 2022: Shandong Huimeng Bio-tech listed 2,000 t/yr of CTF for fluazifop-P-butyl, haloxyfop-R-methyl and chlorfluazuron (Shandong Huimeng Bio-tech)
– Sep 2018: Inner Mongolia Yuanzheng Fine Chemicals neared trial production of pyridine intermediates and haloxyfop-R-methyl units with fluazifop-P-butyl planned (AgroPages)

What this means for the market
Herbicide makers outside China depend on a few Chinese CTF producers that can divert volume to DCTF when that margin is higher. Buyers should watch DCTF demand as a signal of CTF tightness. Toxicity classification raises logistics cost for small importers.

Strategic scenarios to 2047
– Base: Merchant volume grows 4-5% a year to 2035 on fluazifop and pyridalyl demand, then 3% to 2047.
– Constrained supply: Strong DCTF demand pulls CTF into captive conversion, tightening merchant supply and lifting prices 25-40%.
– Technology transition: Cyclo-condensation routes from CF3 building blocks reduce reliance on picoline chlorofluorination for pharma grades.
The swing factor for CTF is CTF diversion into DCTF. Signposts: DCTF prices, 3-picoline supply, fluazifop-P-butyl registrations, Chinese park inspections, HF prices.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: Herbicides, Insecticides, Pharmaceutical intermediates, Liquid-crystal and specialty; end use: Fluazifop-P-butyl, Haloxyfop, Chlorfluazuron, Pyridalyl, APIs; region: China, India, North America, Europe, Japan and rest of world. Each segment is backed by a producer capacity map, trade data and the Market Krystal estimate log, with scenarios to 2047 and strategic recommendations.